Western blotting and RT-PCR were performed to validate the above results, and we found that knocking down MBD2 inhibited the expression of ABCB1, whereas the opposite effect was observed in CCA cells overexpressing MBD2 (Fig. 3D-E). The gene discussed is MBD2; the disease is cholangiocarcinoma.